- Home
- MGY vs CORT Comparison
MGY vs CORT Comparison
Compare MGY & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGY
- CORT
- Stock Information
- Founded
- MGY 2017
- CORT 1998
- Country
- MGY United States
- CORT United States
- Employees
- MGY N/A
- CORT N/A
- Industry
- MGY Oil & Gas Production
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MGY Energy
- CORT Health Care
- Exchange
- MGY Nasdaq
- CORT Nasdaq
- Market Cap
- MGY 5.2B
- CORT 5.9B
- IPO Year
- MGY 2017
- CORT N/A
- Fundamental
- Price
- MGY $22.89
- CORT $51.40
- Analyst Decision
- MGY Buy
- CORT Strong Buy
- Analyst Count
- MGY 13
- CORT 4
- Target Price
- MGY $26.36
- CORT $75.25
- AVG Volume (30 Days)
- MGY 2.2M
- CORT 908.1K
- Earning Date
- MGY 02-12-2025
- CORT 02-13-2025
- Dividend Yield
- MGY 2.27%
- CORT N/A
- EPS Growth
- MGY N/A
- CORT 57.97
- EPS
- MGY 2.02
- CORT 1.26
- Revenue
- MGY $1,311,905,000.00
- CORT $628,555,000.00
- Revenue This Year
- MGY $8.48
- CORT $46.29
- Revenue Next Year
- MGY $1.73
- CORT $17.09
- P/E Ratio
- MGY $11.31
- CORT $40.77
- Revenue Growth
- MGY 4.67
- CORT 39.67
- 52 Week Low
- MGY $19.16
- CORT $20.84
- 52 Week High
- MGY $29.02
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- MGY 24.55
- CORT 37.49
- Support Level
- MGY $25.47
- CORT $53.51
- Resistance Level
- MGY $24.50
- CORT $60.90
- Average True Range (ATR)
- MGY 0.70
- CORT 2.69
- MACD
- MGY -0.42
- CORT -1.24
- Stochastic Oscillator
- MGY 4.57
- CORT 11.31
About MGY Magnolia Oil & Gas Corporation
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The Company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.